Company
Since its founding in 1989, Lyomark Pharma has become an experienced and reliable partner to the pharmaceutical industry.



About Us
Through many years of extensive experience in all areas of pharmaceuticals – from manufacturing to sales – Lyomark has developed into an experienced and reliable partner for the pharmaceutical industry!
Lyomark Pharma was founded in 1989 as a contract manufacturer of active pharmaceutical ingredients and finished products for niche markets in Oberhaching, near Munich. As the name suggests, Lyomark is a service provider for lyophilised and liquid sterile products and has established itself in this sector of the pharmaceutical industry for over 25 years.
Services for pharmaceutical clients include manufacturing, as well as the provision and maintenance of dossiers and the submission of national and international approvals for well-known pharmaceutical companies.
Philosophy
Customer focus combined with outstanding service quality will always be the company's top priority.
The philosophy of the medium-sized company is to accept and master national and international challenges in all areas – from production to sales. Lyomark Pharma's recipe for success lies in remaining flexible at all times and being able to react immediately to changing market conditions while complying with the ever-increasing regulatory framework.
Through this philosophy, the medium-sized company has achieved constant development and steady growth in recent years. Every Lyomark Pharma employee is aware of their individual influence on business success. Customer focus, combined with high service quality, is and remains the company's top priority.
Team
We see Lyomark's culture as a competitive advantage and strive to create an environment where smart, motivated and creative people can thrive.
Behind our products, solutions, and services is a team of professionals with extensive experience and knowledge in the pharmaceutical sector. Our employees are dedicated team players, bringing energy, ideas and pride to their work.
Since 1 October 2021, Dr Wolfgang Burger has taken over the management. Dr Burger has over 30 years of experience in the pharmaceutical industry, most recently as Managing Director of PharmaZell GmbH.
With effect from 1st April 2022, Dr. Dirk Hütten has joined Mr. Dr. Burger on the management board. Dr. Hütten has over 20 years of experience in various international sales roles along the pharmaceutical product supply chain.
Milestones
Integration of Lyomark Pharma as a service provider for the manufacture of Edelfosine.
1998
In November, Dr. Helmut Wolf will become Chief Executive Officer.
1994
Extension for a contract manufacturing service provider for sterile
Products with somatostatin as the first product.
1995
Development of Octreotide.
2001
Vancomycin development.
2002
Submission of international registrations for Lyomark generics.
2003
International sales partner for medicinal products and active ingredients.
2005
Acquisition of Alveofact® from Boehringer Ingelheim.
Founding of the sister company Bendalis GmbH.
2006
Establishment of your own sales organisation in Germany.
2007
International registrations for Alveofact®.
2009
Approval of Ciprofloxacin, Levofloxacin and Fluconazole.
2014
Approval of NeoKay® in Germany.
2016
Acquisition of a majority stake in LYOCONTRACT.
2017
Quality Management
We will gladly provide you with information on our quality policy upon request.
Lyomark Pharma GmbH places great importance on quality.
With GMP and GDP certification, as well as a manufacturing and wholesale licence, we meet all expectations for the production and distribution of our products.
This means all our customers and stakeholders can rely on Lyomark Pharma's quality standards.
Our sister company, Bendalis GmbH, was founded in 2006 and specialises in the development and marketing of high-quality oncology medicines for the treatment of cancer.
As a company with global operations, based in Germany, we see it as our responsibility to provide our customers with products of impeccable quality, manufactured to European quality standards.
